ST. VINCENTS BLOUNT — History
CCN 011305 | 3-year financial timeline | COVID resilience: 32/100
🛡️ Public data only — no PHI permitted on this instance.
$25M
Latest Revenue (FY2022)
-0.3%
Revenue CAGR (3yr)
-33.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $25M | $27M | $25M | -7.4% | -0.3% |
| Operating Expenses | $27M | $31M | $33M | +6.3% | +10.5% |
| Operating Margin | -8.4% | -15.9% | -33.1% | -107.7% | +0.0% |
| Net Income | $-2M | $-4M | $-8M | -92.3% | +0.0% |
| Licensed Beds | 25 | 25 | 25 | +0.0% | +0.0% |
| Total Patient Days | 4,914 | 5,010 | 3,860 | -23.0% | -11.4% |
| Medicare Day % | 36% | 27% | 35% | +27.3% | -2.3% |
| Medicaid Day % | 3% | 4% | 4% | -5.5% | +10.1% |
COVID Impact & Recovery
Resilience Score: 32/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -0.6% ($25M → $25M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▶ Stable
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-0.3%
This Hospital
+7.6%
State Avg
Latest Margin
-33.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $25M | -45.4% |
| FY2024 (proj) | $25M | -57.8% |
| FY2025 (proj) | $25M | -70.1% |